Ying Huang Selected Research

Membrane Transport Proteins (Biological Pump)

4/2009	Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins.
9/2007	Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.
3/2007	Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
8/2006	Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.
6/2004	Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Huang Research Topics

Disease

351	Neoplasms (Cancer) 12/2022 - 04/2002
89	Infections 11/2022 - 03/2003
68	Inflammation (Inflammations) 06/2022 - 06/2008
43	Neoplasm Metastasis (Metastasis) 12/2022 - 02/2006
41	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2004
39	Carcinogenesis 01/2022 - 09/2004
37	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2002
35	Lung Neoplasms (Lung Cancer) 06/2022 - 09/2007
32	Rectal Neoplasms (Rectal Cancer) 01/2022 - 10/2011
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2009
27	Nasopharyngeal Carcinoma 01/2022 - 07/2003
24	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 08/2010
23	Carcinoma (Carcinomatosis) 01/2022 - 01/2004
23	Atherosclerosis 01/2021 - 03/2006
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 09/2007
22	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2002
21	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 04/2005
20	Adenocarcinoma 09/2021 - 08/2008
19	COVID-19 07/2022 - 01/2020
19	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2007
19	Body Weight (Weight, Body) 03/2022 - 02/2008
19	Hypoxia (Hypoxemia) 01/2022 - 12/2005
18	Type 2 Diabetes Mellitus (MODY) 06/2022 - 06/2008
17	Hypertension (High Blood Pressure) 11/2022 - 12/2010
17	Fibrosis (Cirrhosis) 08/2022 - 01/2012
17	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 04/2011
17	Asthma (Bronchial Asthma) 01/2021 - 04/2006
14	Obesity 11/2022 - 11/2007
13	Melanoma (Melanoma, Malignant) 12/2022 - 02/2003
13	Rheumatoid Arthritis 01/2022 - 01/2013
13	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2009
13	Leukemia 01/2021 - 12/2005
13	Myocardial Infarction 01/2019 - 01/2012
11	Hemorrhage 09/2022 - 03/2001
11	Heart Failure 06/2022 - 08/2015
11	Pain (Aches) 02/2022 - 09/2009
11	Esophageal Squamous Cell Carcinoma 01/2022 - 06/2006
10	Wounds and Injuries (Trauma) 02/2022 - 10/2010
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2012
10	Acute Promyelocytic Leukemia 07/2021 - 05/2002
9	HIV Infections (HIV Infection) 01/2022 - 09/2011
9	Sepsis (Septicemia) 01/2022 - 01/2006
9	Multiple Myeloma 12/2021 - 10/2015
9	Virus Diseases (Viral Diseases) 10/2021 - 05/2008
9	Diarrhea 01/2021 - 07/2009
9	Acquired Immunodeficiency Syndrome (AIDS) 12/2020 - 01/2007
9	Ischemia 10/2020 - 03/2009
8	Stroke (Strokes) 01/2022 - 11/2010

Drug/Important Bio-Agent (IBA)

136	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2004
83	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
63	Pharmaceutical PreparationsIBA 07/2022 - 04/2003
37	CytokinesIBA 01/2022 - 12/2005
31	Messenger RNA (mRNA)IBA 12/2021 - 10/2003
30	MicroRNAs (MicroRNA)IBA 06/2022 - 11/2010
30	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
28	VaccinesIBA 06/2022 - 07/2010
27	Biological ProductsIBA 01/2022 - 02/2003
19	Therapeutic UsesIBA 11/2022 - 01/2002
19	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 09/2006
19	EnzymesIBA 01/2021 - 08/2004
16	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2009
15	AntioxidantsIBA 06/2022 - 03/2010
15	C-Reactive ProteinIBA 01/2021 - 02/2013
14	Small Interfering RNA (siRNA)IBA 11/2022 - 06/2004
14	Peptides (Polypeptides)IBA 08/2022 - 10/2010
14	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2011
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2004
14	LipidsIBA 01/2022 - 04/2010
14	AntigensIBA 12/2021 - 10/2007
14	AntibodiesIBA 07/2021 - 11/2007
14	CholesterolIBA 01/2018 - 12/2009
13	Interleukin-10 (Interleukin 10)IBA 03/2022 - 08/2011
13	InterleukinsIBA 01/2022 - 01/2009
13	Phosphotransferases (Kinase)IBA 10/2021 - 01/2006
13	LipopolysaccharidesIBA 03/2021 - 01/2013
11	CollagenIBA 02/2022 - 08/2009
10	Carvedilol (Coreg)FDA LinkGeneric 01/2022 - 09/2013
10	CateninsIBA 01/2022 - 11/2014
10	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2005
9	Blood Glucose (Blood Sugar)IBA 06/2022 - 12/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 12/2015
9	CarbohydratesIBA 01/2022 - 05/2011
9	Carrier Proteins (Binding Protein)IBA 01/2022 - 12/2002
9	Oxygen (Dioxygen)IBA 05/2021 - 06/2006
9	ErbB Receptors (EGF Receptor)IBA 12/2019 - 09/2007
9	LigandsIBA 01/2019 - 07/2005
8	Indicators and Reagents (Reagents)IBA 10/2022 - 10/2009
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2010

Therapy/Procedure

138	Therapeutics 12/2022 - 04/2003
50	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
37	Radiotherapy 04/2022 - 07/2003
29	Neoadjuvant Therapy 01/2022 - 06/2014
18	Chemoradiotherapy 06/2021 - 04/2005
13	Immunotherapy 02/2022 - 01/2012
13	Aftercare (After-Treatment) 04/2021 - 05/2005
13	Chemoprevention 11/2020 - 05/2002
12	Ligation 01/2022 - 09/2005
9	Lasers (Laser) 02/2022 - 09/2005
9	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018 - 09/2012
9	Stents 07/2015 - 02/2007